WallStreetZenWallStreetZen

NASDAQ: EPIX
Essa Pharma Inc Earnings & Revenue

EPIX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$27.7M
Current Profit Margin
0%

EPIX Return on Equity

Current Company
-20.2%
Current Industry
22.9%
Current Market
33.8%
EPIX's Return on Equity (-20.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EPIX announces earnings.

EPIX Return on Assets

Current Company
-19.6%
Current Industry
3.5%
EPIX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EPIX Return on Capital Employed

Current Company
-21.43%
Current Industry
21.4%
EPIX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EPIX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EPIX$0.00-$27.57M-$27.67MN/AN/A
TCRX$12.20M-$95.73M-$104.41M+101.54%N/A
SLDB$0.00-$86.90M-$90.69M-100.00%N/A
AKBA$174.50M$11.86M-$40.44M-9.44%N/A
ADCT$66.75M-$121.01M-$216.66M+255.87%N/A

Essa Pharma Earnings & Revenue FAQ

What were EPIX's earnings last quarter?

On Invalid Date, Essa Pharma (NASDAQ: EPIX) reported Q2 2024 earnings per share (EPS) of -$0.16, up 5.88% year over year. Total Essa Pharma earnings for the quarter were -$7.23 million. In the same quarter last year, Essa Pharma's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Essa Pharma stock.

What was EPIX's earnings growth in the past year?

As of Q3 2024, Essa Pharma's earnings has grown year over year. Essa Pharma's earnings in the past year totalled -$27.67 million.

What was EPIX's revenue last quarter?

On Invalid Date, Essa Pharma (NASDAQ: EPIX) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Essa Pharma's revenue was $0.00.

What was EPIX's revenue growth in the past year?

As of Q3 2024, Essa Pharma's revenue has grown null year over year. Essa Pharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.